ArticleLancet (London, England)2024
Mpox declared a public health emergency.
Article in Lancet (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Epidemiological and clinical characteristics of Peruvian patients with mpox: A systematic review and meta-analysis.PloS one · 2025Pooled it
- Integrating explainable AI and One Health: a new frontier in combating infectious diseases.EBioMedicine · 2026Article
- Mpox Outbreak in the East Africa Region: Current Status, Containment Measures, Challenges, and Future Direction.Public health challenges · 2026Review
- SWOT analysis of Mpox surveillance in high-burden districts in Uganda, February-March 2025.One health outlook · 2026Article
- Beyond counting the numbers - focused outbreaks response strategies are needed to control the mpox outbreak in Africa.One health outlook · 2026Article
- Viral emergence and pandemic preparedness in a One Health framework.Nature reviews. Microbiology · 2026Review
- Public health and community support for prevention of novel viral diseases: a qualitative study with LGBTQIA + people and people with blood-borne viruses.BMC health services research · 2025Article
- AI-driven discovery of antiretroviral drug bictegravir and etravirine as inhibitors against monkeypox and related poxviruses.Communications biology · 2025Article
- Article
- Strengthening the mpox response: how do we balance pragmatism and equity in resource-constrained settings?Journal of global health · 2025Article
- Key drivers for mpox control at its source to reduce costs amid aid cuts to Africa.Nature medicine · 2025Article
- 'It was something that I let slip by the wayside': a qualitative study of challenges to equitable mpox vaccination in the UK outbreak response.BMC public health · 2025Article
- The Cluster of Mpox (Clade Ib) Infections - Yiwu City, Zhejiang Province, China, July-August 2025.China CDC weekly · 2025Article
- The Trans-Kingdom Spectrum of Mpox-like Lesion Pustules of Suspect Patients in the Mpox Clade Ib Outbreak in Eastern Democratic Republic of the Congo.Microorganisms · 2025Article
- Serological evidence of clade Ib Mpox transmission by sex workers and within household in South Kivu, DRC.Nature communications · 2025Article
- A new attenuated and highly immunogenic orthopoxvirus vaccine protects against mpox in mice and macaques.NPJ vaccines · 2025Article
- Discovery ofACS medicinal chemistry letters · 2025Article
- Review
- Recurrent Mpox: divergent virulent clades and the urgent need for strategic measures including novel vaccine development to sustain global health security.BMC infectious diseases · 2025Review
- Multivalent vaccine candidate from conserved immunogenic peptides in entry or exit proteins of Orthopoxvirus genus.Scientific reports · 2025Article
Corrections and comments
- Commented on by
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
39182498What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.